In many parts of India, soaring temperatures are not only a matter of discomfort but are also influencing the demand for medications that help manage chronic health conditions. This includes medicines for high blood pressure, cholesterol, blood clotting, oral electrolytes, and sunscreens.

According to market researcher Pharmarack, the demand for certain medications has significantly increased due to the hot and humid weather. Let's get deeper into how the rising temperatures are impacting medication sales and health trends across the country.

Rising Demand for Chronic Condition Medications: The scorching heat has led to a surge in sales of medications used to manage chronic conditions like high blood pressure (antihypertensives), cholesterol (lipid-lowering drugs), and blood clotting (platelet aggregation inhibitors).

1. Antihypertensives

Sales of antihypertensive drugs have shown a steady increase, reaching ₹1,134 crore in April compared to ₹1,129 crore in March and ₹1,119 crore in February. Over the past 12 months through April 2024, antihypertensive drugs recorded a Moving Annual Turnover (MAT) of ₹13,468 crore.

2. Lipid-Lowering Drugs

Similarly, sales of lipid-lowering drugs have risen from ₹520 crore in February to ₹541 crore in April, reflecting the growing demand for medications that manage cholesterol levels.

3. Platelet Aggregation Inhibitors

The hot and humid weather has also contributed to an increase in sales of platelet aggregation inhibitors, which prevent platelet adhesion and work at different stages of the clotting cascade. Sales of these drugs rose from ₹112 crore in February to ₹114 crore in April.

Oral Electrolytes and Sunscreens: With temperatures soaring, the need for hydration management has led to a twofold increase in the consumption of oral electrolytes this year. This surge highlights the importance of staying hydrated, especially during the hot summer months.

Skincare Preferences in Hot Weather: In addition to medications, the cosmo derma segment has witnessed an increase in both value and unit consumption. In April, segments such as emollients, protectives, and sunscreens experienced steady growth, driven by escalating skincare preferences among consumers.

Market Growth and Resilience: Despite the challenging conditions, the Indian Pharmaceutical Market (IPM) demonstrated robust growth in April, reaching a value of ₹16,413 crore, which marks a 9.2% increase compared to the previous year. On a Moving Annual Turnover (MAT) basis, the IPM showcased resilience, achieving ₹1,99,288 crore with a value growth of 7.3%.

As temperatures continue to rise across India, the demand for medications that manage chronic health conditions and support hydration and skincare needs is expected to remain high. It's essential for individuals to prioritize their health during hot weather by staying hydrated, using sun protection, and managing chronic conditions effectively with the help of prescribed medications.